Innate immune pathway modulator screen identifies STING pathway activation as a strategy to inhibit multiple families of arbo and respiratory viruses
cGAS-STING pathway
Biomedical and clinical sciences
respiratory syncytial virus
Immunology
CHIKV
610
Antiviral Agents
Article
Zika virus
Mice
Rare Diseases
WNV
EV-D68
pattern-recognition receptors
Biodefense
616
Genetics
2.1 Biological and endogenous factors
Innate
STING activator cAIMP blocks ZIKV
Animals
RNA Viruses
Biomedical and Clinical Sciences
SARS-CoV-2
Zika Virus Infection
Inflammatory and immune system
enterovirus-D68
Immunity
COVID-19
Zika Virus
Immunity, Innate
3. Good health
Vector-Borne Diseases
Emerging Infectious Diseases
Infectious Diseases
Good Health and Well Being
Medical Microbiology
5.1 Pharmaceuticals
antiviral activity
cAIMP
Infection
West Nile virus
Chikungunya virus
scleroglucan
DOI:
10.1016/j.xcrm.2023.101024
Publication Date:
2023-04-28T14:36:13Z
AUTHORS (18)
ABSTRACT
RNA viruses continue to remain a threat for potential pandemics due their rapid evolution. Potentiating host antiviral pathways prevent or limit viral infections is promising strategy. Thus, by testing library of innate immune agonists targeting pathogen recognition receptors, we observe that Toll-like receptor 3 (TLR3), stimulator interferon genes (STING), TLR8, and Dectin-1 ligands inhibit arboviruses, Chikungunya virus (CHIKV), West Nile virus, Zika varying degrees. STING (cAIMP, diABZI, 2',3'-cGAMP) agonist scleroglucan demonstrate the most potent, broad-spectrum function. Furthermore, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enterovirus-D68 (EV-D68) infection in cardiomyocytes. Transcriptome analysis reveals cAIMP treatment rescue cells from CHIKV-induced dysregulation cell repair, immune, metabolic pathways. In addition, provides protection against CHIKV chronic CHIKV-arthritis mouse model. Our study describes signaling circuits crucial replication identifies antivirals effective multiple families pandemic viruses.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (83)
CITATIONS (21)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....